Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
Clinical trial NCT03373227 · COMPLETED
Trial details
- NCT number
- NCT03373227
- Sponsor
- Baylor Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2023-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.